Peripheral artery disease: vizsgálatok itt: Litvánia

1 trial · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

• 3. fázisNot yet taking people in Litvánia
  Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  Where

  Kaunas

  Életkor

  18 év and over

  People

  7050 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT07318610 · EU 2025-522954-37-00